Vr Adviser, LLC Keros Therapeutics, Inc. Transaction History

Vr Adviser, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$29.27 - $43.71 $7.97 Million - $11.9 Million	-272,306 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$42.4 - $70.11 $4.24 Million - $7.01 Million	-100,000 Reduced 26.86%	272,306 $11.6 Million
Q1 2021 May 14, 2021	SELL	$54.0 - $75.28 $16.2 Million - $22.6 Million	-300,000 Reduced 44.62%	372,306 $22.9 Million
Q2 2020 Aug 14, 2020	BUY	$20.08 - $40.39 $13.5 Million - $27.2 Million	672,306 New	672,306 $25.2 Million

174

30.3M

76.8K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.39B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

Stay updated on Vr Adviser, LLC with notifications on news.